DrugPatentWatch Database Preview
« Back to Dashboard
Summary for Patent: 9,012,508
|Title:||Administration of intravenous ibuprofen|
|Abstract:||An effective dose of intravenous ibuprofen administered every 6 hours in surgery patients is a safe and effective way to reduce both pain and the need for morphine. In preferred embodiments, the administration of intravenous ibuprofen starts with the onset of anesthesia.|
|Inventor(s):||Pavliv; Leo (Cary, NC)|
|Assignee:||Cumberland Pharmaceuticals (Nashville, TN)|
1. A method for reducing surgical pain in human patients, consisting of (i) treating post-surgical pain by administering a first dose of intravenous ibuprofen solution
in an amount of about 800 mg prior to the start of surgery on the patients, (ii) intravenously administering a further dose of 800 mg dose of intravenous ibuprofen about every six hours post-operatively to the patients at least until 24 hours after
surgery and about every 6 hours from about 24 hours after surgery up to about 5 days after surgery; and (iii) administering morphine, an opioid analgesic, post-operatively to the patients in an amount which is reduced by about 20% or more within the
first 24 hours after surgery than that typically required to control pain in human patients having undergone the same surgical procedure without said administration of ibuprofen, such that the human patients receiving intravenous ibuprofen experience
about a 30% reduction in mean morphine consumption.
2. The method of claim 1, wherein the patients experience a significant reduction in pain as measured by the VAS with movement and/or the VAS at rest area under the curve for time points within the first 24 hours after surgery.
3. The method of claim 1, provides a reduction in side effects associated with the administration of opioid analgesics.
4. The method of claim 1, wherein the patient undergoes a surgical procedure selected from orthopedic surgery, gynecologic surgery, major abdominal surgery, lower abdominal, and general investigative surgery.
5. The method of claim 1, wherein the ibuprofen being intravenously administered after surgery improves the time to ambulation and significantly reduces pain scores in the patients, as compared to such patients receiving opioid analgesics without said administration of ibuprofen.
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally: